Canton Strategic (CNTN) vs enGene Therapeutics (ENGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Canton Strategic (CNTN) has outperformed enGene Therapeutics (ENGN) over the past year, losing 34.6% versus a loss of 76.0%. Canton Strategic is the larger company by market cap ($165.7 million vs $119.3 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNTN | ENGN |
|---|---|---|
| Share price | $2.08 | $1.78 |
| Market cap | $165.74M | $119.29M |
| 1-day change | -7.96% | +2.01% |
| YTD return | -31.35% | -80.29% |
| 1-year return | -34.59% | -75.98% |
| EPS (TTM) | $-0.10 | $-2.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.89 | $12.25 |
| 52-week low | $1.75 | $1.40 |
| Distance from 52-week high | -69.81% | -85.47% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +84.83% |
| Average volume | 758.86K | 746.58K |
| Shares outstanding | 79.68M | 67.02M |
| Employees | 12 | 81 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CNTN has outperformed ENGN by 41.4 percentage points over the past year.
About Canton Strategic
CNTN stock →Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States.
Healthcare · Biotechnology · 12 employees
About enGene Therapeutics
ENGN stock →enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer.
Healthcare · Biotechnology · 81 employees
CNTN vs ENGN FAQ
Which is bigger, Canton Strategic or enGene Therapeutics?
Canton Strategic (CNTN) is larger, with a market capitalization of $165.74M compared with $119.29M for enGene Therapeutics (ENGN).
Which stock has performed better over the past year, CNTN or ENGN?
CNTN returned -34.59% over the past 12 months, compared with -75.98% for ENGN (price return, excluding dividends). Past performance does not predict future results.
Are Canton Strategic and enGene Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.